Tuesday, January 24, 2023

< + > The End Of Obesity

Since its 2021 launch, Novo Nordisk’s Wegovy set the stage for the next generation of anti-obesity drugs that target the gut’s weight-regulating mechanisms. Now, a new drug on the scene promises to be more effective and safer than any other weight loss drug before.

No comments:

Post a Comment

< + > Onyx, the Leading CMS Interoperability Platform, Acquires InteropX to Accelerate Electronic Prior Auth & Data Exchange

Acquisition Strengthens Onyx’s Ability to Help Health Plans Modernize ePA, Scale to Meet CMS Deadlines, and Maximize Value of Interoperabili...